Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2003
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055083 Method of providing an antihistaminic effect in a hepatically impaired patient
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055045 Novel compounds with analgesic effect
03/20/2003US20030055040 Cholinesterase inhibitors to treat disorders of attention
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1173179B1 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP0963370B1 Integrin antagonists
03/19/2003EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534525 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
03/18/2003US6534522 Subtype-selective NMDA receptor ligands and the use thereof
03/18/2003US6534499 For therapy of autoimmune disease
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2003020281A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/13/2003WO2003020275A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002102743A3 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030049205 That undergoes/interferes with cytochrome P450 metabolism, using d-threo-methylphenidate; side effect reduction of drug-drug interaction toxicity; tricyclic antidepressants or selective serotonin reuptake inhibitors
03/13/2003CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
03/13/2003CA2455896A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289954A1 Serine protease inhibitors
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289941A1 Carbamic acid esters as inhibitors of factor xa
03/12/2003EP1289527A2 Use of (+)-alpha -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
03/12/2003EP1289498A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1086073B1 Method for preparing alkoxyamines from nitroxides
03/12/2003CN1102927C Prepn. of 1-butyl-4-piperidinylmethylamine
03/11/2003US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
03/11/2003US6531562 Such as 2-(1-tert- butoxycarbonylpiperidin-2-yl)ethyl 5-norbornene-2-carboxylate; photolithography; etching/heat resistance; semiconductors
03/11/2003US6531490 Production of agglomerates of inogatran and the compound inogatran anhydrate
03/11/2003US6531489 Single isomer methylphenidate and resolution process
03/11/2003US6531481 Opiate compounds, methods of making and methods of use
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/07/2003WO2002020481A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421835A1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridines
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018543A1 Novel cyclohexyl sulphones
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003017998A1 Platinum complexes and their use in cancer treatment
03/06/2003WO2003017948A2 Aryl tetrahydronaphthalene derivatives
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002102381A9 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045722 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
03/06/2003US20030045721 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
03/06/2003US20030045530 Administering a piperazine or piperidine coupled through a linker to a benzhydril
03/06/2003US20030045516 Chemokine receptor antagonists and methods of use therefor
03/06/2003US20030045461 Composition and methods of esterified nitroxides gated with carboxylic acids
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/06/2003CA2456348A1 Platinum complexes and their uses in therapy
03/05/2003EP1288198A1 Process for the production of sulfonic esters
03/05/2003EP1288195A1 Cationic nitrile compounds and compositions containing them
03/05/2003EP1287826A1 A crystalline form of the free base of Amlodipine
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286966A1 4-aminopiperidine derivatives and their use as medicine
03/05/2003EP1286965A1 Piperidine compounds and process for providing such
03/05/2003EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP0942901B1 Cyclic imines as pesticides
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 380